Relmada Therapeutics Inc (NAS:RLMD)
$ 6.67 +0.24 (+3.72%) Market Cap: 699.74 Mil Enterprise Value: 468.40 Mil PE Ratio: 0 PB Ratio: 3.20 GF Score: 29/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1